HBK Investments’s Amgen AMGN Stock Holding History

HBK Investments’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-400,000	Closed	-$65.6M	–	908
2017 Q1	$65.6M	Buy	+400,000	New	+$66.5M	0.53%	23

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HBK Investments's AMGN Position: Q1 2020 in Review

HBK Investments sold out of Amgen (AMGN) in Q1 2020, closing a stake of 16,033 shares — an estimated $3.87M sold.

HBK Investments first reported a position in AMGN in Q4 2014 and held it in 15 quarters. The position peaked at $62.5M in Q1 2017. 2,030 funds tracked by Wall St. Rank hold AMGN as of Q1 2020.

HBK Investments reported no remaining Amgen position as of Q1 2020 after selling out during the quarter.
HBK Investments sold 16,033 Amgen shares in Q1 2020, an estimated $3.87M.
HBK Investments first reported a position in Amgen in Q4 2014 and held it in 15 quarters.
HBK Investments's Amgen position peaked at $62.5M in Q1 2017.
2,030 funds tracked by Wall St. Rank held Amgen as of Q1 2020.

Based on HBK Investments's 13F filing for Q1 2020, filed 15 May 2020.